CAPLIN POINT LABORATORIES LTD.
Smart Quotes
Trade Value (Rs. in Lacs) | 0.00 |
Dividend Yield(%) | 0.35 |
TTM EPS (Rs.) | 35.31 |
P/E Ratio | 36.78 |
Book Value (Rs.) | 174.00 |
Face Value (Rs.) | 2 |
MCap (Rs. in Mn) | 98633.14 |
Price/Earning (TTM) | 33.48 |
Price/Sales (TTM) | 15.65 |
Price/Book (MRQ) | 7.46 |
PAT Margin (%) | 44.32 |
ROCE (%) | 28.33 |
Management Info :
C C Paarthipan - Chairman Sridhar Ganesan - Managing DirectorRegistered Office :
Address :
3rd Floor, “ Ashvich Towersâ€,No.3, Developed Plots Industrial Estate,Perungudi,
Chennai,
Tamil Nadu-600096
Phone : 044-24968000 / 8012772888 / 71148000
Email : info@caplinpoint.net
Website : www.caplinpoint.net
QTR Dec 23 | ANNUAL 23 | |
---|---|---|
Net Profit | 554.5 | 2342.6 |
Gross Profit | 744.3 | 2931.5 |
Operating Profit | 812.2 | 3189.2 |
Net Sales | 1328.3 | 5286.1 |
Ajanta Pharma (BSE)  2377.00 (6.44%) | M.Cap ( in Cr) 29930.39 |
Alkem Laboratories (BSE)  4899.45 (2.36%) | M.Cap ( in Cr) 58580.27 |
Astrazeneca Pharma I (BSE)  5424.45 (1.70%) | M.Cap ( in Cr) 13561.13 |
Dr. Reddy's Lab (BSE)  6349.95 (0.98%) | M.Cap ( in Cr) 105928.76 |
Torrent Pharma (BSE)  2732.60 (2.20%) | M.Cap ( in Cr) 92483.60 |
|
PROMOTERS | 70.62 % |
|
NON-INSTITUTION | 24.95 % |
|
MUTUAL FUNDS/UTI | 1.06 % |
|
FI/BANKS/INSURANCE | 0 % |
|
GOVERNMENT | 0 % |
|
FII | 0 % |
Scheme Name | Hold(%) |
---|---|
UTI Healthcare Fund-Reg... | 1.39 |
ITI Pharma & Healthcare... | 1.21 |
UTI Small Cap Fund-Reg(G) | 1.08 |
UTI Large & Mid Cap Fun... | 0.49 |
UTI Aggressive Hybrid F... | 0.48 |
Motilal Oswal S&P BSE H... | 0.29 |